Immunome Inc.
IMNMDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How IMNM's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AL102 | Phase 3 | Desmoid | - | - |
Frequently asked questions
What is in Immunome Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Immunome Inc.'s (IMNM) pipeline across Phase 3. Its lead program is AL102 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Immunome Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Immunome Inc. (IMNM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IMNM biotech catalysts?→
Add IMNM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Immunome Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.